Gain of minimum 10 ETDRS letters (n = 10) | VA change of less than 10 ETDRS letters (n = 56) | Loss of minimum 10 ETDRS letters (n = 16) | P-value Kruskal-Wallis test | |
---|---|---|---|---|
CCL11 plasma level Median (IQR) | 473.6 (408.9;580.7) | 534.1 (323.0;710.6) | 427.7 (243.7;762.5) | 0.725 |
CCR3 positive granulocytes Median (IQR) | 4.85 (3.18;6.08) | 5.50 (4.13;9.67) | 7.30 (3.18;10.7) | 0.530 |
Gain of minimum 15 ETDRS letters (n = 7) | VA change of less than 15 ETDRS letters (n = 64) | Loss of minimum 15 ETDRS letters (n = 11) | ||
CCL11 plasma level Median (IQR) | 432,3 (390.5;635.8) | 541.2 (351.4;699.5) | 349.2 (240.7;667.1) | 0.382 |
CCR3 positive granulocytes Median (IQR) | 4.60 (2.65;6.90) | 5.50 (4.13;9.67) | 8.00 (3.65;10.60) | 0.496 |